| Category : |
Inorganic chemicals |
 |
| CAS NO : |
133040-01-4 |
| EC NO : |
|
| MF : |
C23H24N2O4S |
| MW : |
424.5127 |
| Specification : |
99% |
| Packing : |
1kg/bag, 5kg/bag, or as per customers’ requirements. |
| Product description : |
API(Active Pharmaceutical Ingredient)
Item
Standard
Structural data confirmation
1. H-NMR: The data of structure are identical with reference standard
2. HPLC-MS: Ensure the molecular weight of main peak and fragment peak are identical with reference standard
3. IR:The data of IR are identical with that of reference standard
Purity(HPLC)
≥99.0%
Related impurities
Specific single impurity
Meets EP/USP/BP standards
Non-specific single impurity
≤0.10%
Total Impurities
≤0.50%
Crystal form
Meets EP/USP/BP standards
Loss on drying
≤1.0%
Water
≤1.0%
Inorganic salt
≤0.1%
Heavy metals
≤10 ppm
Assay
98.0%~102.0%(According to EP/USP/BP standards)
Microbiological Analysis
Total plate count
≤1000cfu/g
Yeast and Moulds
≤100cfu/g
E. Coli.
Absent
Salmonella
Absent
S.aureus
Absent
|
| Uses : |
API, pharmaceutical |
| Synonyms : |
Eprosartan Mysylate;(E)-3-[2-Butyl-1-[(4-carboxyphenyl)-methyl]imidazol-5-l]-2-(2-thienylmethyl)-2-propenoic Acid;((E)-3-[2-Butyl-1-[(4-carboxyphenyl)methyl]imidazol-5-yl]-2-(2-thienylmethyl)-2-propenoic Acid;SKF-108566);(E)- α-[[2-Butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-y1]methylene]2-thiophenepropanoic acid;SKF-108566J;Teveten;Eporlosartan;4-({2-butyl-5-[2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid;4-({2-butyl-5-[(1E)-2-carboxy-3-thiophen-2-ylprop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid; |
| Molecular Structure : |
 |